Xiaoling Du
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Sarcoma Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Pluripotent Stem Cells Research 6
- CRISPR and Genetic Engineering 5
-
- Prostate Cancer Treatment and Research 9
- Sarcoma Diagnosis and Treatment 8
- Co-authors
- Jilong Yang (17 shared papers)Jiandang Shi (22 shared papers)Ju Zhang (20 shared papers)Kexin Chen (9 shared papers)Guowen Wang (4 shared papers)Helmut Klocker (10 shared papers)Jonathan C. Trent (4 shared papers)Wenxia Zhou (1 shared paper)
- Journals
- The Prostate (4 papers)Cancer Letters (4 papers)Cell Communication and Signaling (3 papers)Oncotarget (2 papers)Molecular Endocrinology (2 papers)
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Xiaoling Du
51 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 100
- Cancer Research 250
- Pulmonary and Respiratory Medicine 395
- Gastroenterology 57
- Oncology 282
- Urology 51
Countries citing papers authored by Xiaoling Du
This map shows the geographic impact of Xiaoling Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Du more than expected).
Fields of papers citing papers by Xiaoling Du
This network shows the impact of papers produced by Xiaoling Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Du. The network helps show where Xiaoling Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Advances in targeted therapy for osteosarcoma. | 2014 | 117 |
| 2 | 2019 | 85 | |
| 3 | 2008 | 82 | |
| 4 | 2008 | 62 | |
| 5 | 2008 | 59 | |
| 6 | 2017 | 53 | |
| 7 | 2012 | 49 | |
| 8 | 2015 | 48 | |
| 9 | 2009 | 47 | |
| 10 | 2014 | 47 | |
| 11 | 2013 | 46 | |
| 12 | 2016 | 42 | |
| 13 | 2010 | 40 | |
| 14 | 2014 | 38 | |
| 15 | 2017 | 33 | |
| 16 | 2014 | 32 | |
| 17 | 2016 | 31 | |
| 18 | 2014 | 31 | |
| 19 | 2011 | 30 | |
| 20 | 2021 | 28 |
About Xiaoling Du
Xiaoling Du is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Genetics, Cancer Research and Oncology, having authored 53 papers that have together received 1.4k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (9 papers), Prostate Cancer Treatment and Research (9 papers), Sarcoma Diagnosis and Treatment (8 papers), Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (5 papers), Neurofibromatosis and Schwannoma Cases (4 papers), Urinary Bladder and Prostate Research (4 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Cancer Research (250 citations), Pulmonary and Respiratory Medicine (395 citations), Gastroenterology (57 citations), Oncology (282 citations) and Urology (51 citations). Xiaoling Du has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Jilong Yang, Jiandang Shi, Ju Zhang, Kexin Chen, Guowen Wang, Helmut Klocker, Jonathan C. Trent, Wenxia Zhou, Yan Zhu and Alexander J. Lazar. Their work appears in journals such as The Prostate, Cancer Letters, Cell Communication and Signaling, Oncotarget and Molecular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.